GONCX
Price
$27.08
Change
-$0.24 (-0.88%)
Updated
Feb 21 closing price
Net Assets
5.21B
RERBX
Price
$54.18
Change
-$0.50 (-0.91%)
Updated
Feb 21 closing price
Net Assets
131.04B
Ad is loading...

GONCX vs RERBX

Header iconGONCX vs RERBX Comparison
Open Charts GONCX vs RERBXBanner chart's image
JHancock International Growth C
Price$27.08
Change-$0.24 (-0.88%)
VolumeN/A
Net Assets5.21B
American Funds Europacific Growth R2
Price$54.18
Change-$0.50 (-0.91%)
VolumeN/A
Net Assets131.04B
GONCX vs RERBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GONCX vs. RERBX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GONCX is a Buy and RERBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RERBX has more cash in the bank: 131B vs. GONCX (5.21B). GONCX pays higher dividends than RERBX: GONCX (1.67) vs RERBX (1.00). GONCX was incepted earlier than RERBX: GONCX (19 years) vs RERBX (23 years). GONCX is a more actively managed with annual turnover of: 77.00 vs. RERBX (34.00). RERBX has a lower initial minimum investment than GONCX: RERBX (250) vs GONCX (1000). GONCX annual gain was more profitable for investors over the last year : 11.53 vs. RERBX (0.62). RERBX return over 5 years is better than : 4.32 vs. GONCX (-6.34).
GONCXRERBXGONCX / RERBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years23 years-
Gain YTD5.9056.54990%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets5.21B131B4%
Annual Yield % from dividends1.671.00167%
Returns for 1 year11.530.621,865%
Returns for 3 years-8.15-0.322,576%
Returns for 5 years-6.344.32-147%
Returns for 10 years28.5515.57183%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KFS7.66-0.01
-0.13%
Kingsway Financial Services
ENLV1.00-0.02
-1.81%
Enlivex Therapeutics Ltd
PGRE4.52-0.10
-2.16%
Paramount Group
PTC161.65-4.11
-2.48%
PTC
RNA31.12-1.41
-4.33%
Avidity Biosciences